18/04/2015 21:07:25 Free Membership Login

Trinity Biotech News (NASDAQ:TRIB)

DateTimeSource
Headline
04/09/20151:05PMGLOBETrinity Biotech plc Closes Offering of $115 Million of 4.00% Exchangeable Senior Notes Due 2045, Including Exercise in Full o...
DUBLIN, Ireland, April 9, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced today that Trinity Biotech Investment Limited, its wholly-owned subsidiary (the "Issuer"), closed its offering... More...>>
04/02/20159:04AMPRNUSTrinity Biotech plc Prices Offering of $100 Million of 4.00% Exchangeable Senior Notes due 2045
Trinity Biotech plc Prices Offering of $100 Million of 4.00% Exchangeable Senior Notes due 2045 PR Newswire DUBLIN, April 2, 2015 DUBLIN, April 2, 2015 /PRNewswire/ -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced... More...>>
04/01/20154:16PMPRNUSTrinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045
Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 PR Newswire DUBLIN, April 1, 2015 DUBLIN, April 1, 2015 /PRNewswire/ -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets... More...>>
03/25/201512:21PMGLOBETrinity Biotech Announces Filing of 2014 Annual Report
DUBLIN, March 25, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that it has filed its Form 20-F containing audited consolidated financial statements for the year ended December... More...>>
03/03/20156:59PMSEEKTrinity Biotech's (TRIB) CEO Ronan O'Caoimh on Q4 2014 Results - Earnings Call Transcript
http://seekingalpha.com/article/2970456-trinity-biotechs-trib-ceo-ronan-ocaoimh-on-q4-2014-results-earnings-call-transcript?source=partner_advfn More...>>
03/03/20158:47AMGLOBETrinity Biotech Announces Results for Q4 and Fiscal Year 2014
DUBLIN, Ireland, March 3, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for fiscal year 2014 and the quarter ended December 31, 2014. Fiscal year 2014 Results Total revenues... More...>>
03/03/20156:28AMSEEK10 Dandy Dividend Healthcare Dogs Hail 14% February Upsides
http://seekingalpha.com/article/2967816-10-dandy-dividend-healthcare-dogs-hail-14-percent-february-upsides?source=partner_advfn More...>>
02/25/201510:44AMGLOBETrinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2014 Financial Results
DUBLIN, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2014 on Tuesday, March 3, 2015. The Company has scheduled a... More...>>
02/23/201511:25AMSEEKTrinity Biotech restarts U.S. trial
http://seekingalpha.com/news/2316976-trinity-biotech-restarts-u-s-trial?source=partner_advfn More...>>
02/23/201510:18AMGLOBETrinity Biotech Announces Recommencement of US Clinical Trials on Its Point-of-Care, High Sensitivity Troponin I Product
DUBLIN, Ireland, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that late last week it shipped Meritas Troponin I product to the USA for the immediate recommencement... More...>>
01/06/20157:30PMGLOBECutera Appoints Clint Severson and J. Daniel Plants to Board of Directors
BRISBANE, Calif., Jan. 6, 2015 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, today announced several changes to the composition and structure of its Board of Directors. Mr. Clint Severson joins Cutera as an independent... More...>>
12/16/201411:26AMGLOBETrinity Biotech Announces CLIA Waiver of Rapid Syphilis Test
DUBLIN, Ireland, Dec. 16, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that a CLIA waiver has been received for Syphilis Health Check – a point-of-care rapid test for... More...>>
07/29/20147:57AMGLOBETrinity Biotech Announces Quarter 2 Financial Results; 25% Increase in Operating Profits
DUBLIN, July 29, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2014. Quarter 2 Results                                                       ... More...>>
07/21/20145:31AMGLOBETrinity Biotech plc to Announce Second Quarter Fiscal Year 2014 Financial Results
DUBLIN, July 21, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2014 on Tuesday, July 29, 2014. The Company has scheduled a conference... More...>>
04/29/20149:54AMGLOBETrinity Biotech Announces Quarter 1 Results
Revenues Up 23%, Operating Profit Up 16% Increase in Dividend to 22 Cents DUBLIN, April 29, 2014 (GLOBE NEWSWIRE) --Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31... More...>>
04/16/20148:43AMGLOBETrinity Biotech plc to Announce First Quarter Fiscal Year 2014 Financial Results
DUBLIN, April 16, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2014 on Tuesday, April 29, 2014. The Company has scheduled a conference... More...>>
03/04/20149:31AMGLOBETrinity Biotech Announces Results for Q4 and Fiscal Year 2013
DUBLIN, March 4, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for fiscal year 2013 and the quarter ended December 31, 2013. Fiscal year 2013 Results Total revenues for... More...>>
02/19/20148:07AMGLOBETrinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2013 Financial Results
DUBLIN, Feb. 19, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter fiscal year 2013 on Tuesday, March 4, 2014. The Company has scheduled a conference... More...>>
01/29/20148:27AMGLOBETrinity Biotech Announces European Approval of Guideline Compliant, Point-of-Care, High Sensitivity Troponin I Product
DUBLIN, Jan. 29, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB) today announced it has obtained the CE mark (i.e. European approval) for its Meritas, high sensitivity Troponin I (hsTnI) product. With its unrivalled precision, it is now the only point-of-care product capable of meeting all of the guidelines... More...>>
10/17/20139:27AMGLOBETrinity Biotech Announces Quarter 3 Financial Results, Acquisition of Blood Bank Screening Business and FDA Approval of HIV-2...
DUBLIN, Ireland, Oct. 17, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2013, the acquisition of the blood bank screening business... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq trib150418 21:07